Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Chouguiyu sequencing

PROVIDER: PRJNA560464 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9983070_1.fastq.gz	Fastqsanger.gz
	SRR9983070_2.fastq.gz	Fastqsanger.gz
	SRR9983080_1.fastq.gz	Fastqsanger.gz
	SRR9983080_2.fastq.gz	Fastqsanger.gz
	SRR9983071_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 42

Similar Datasets

Project description:Chouguiyu sequencing

| PRJNA600780 | ENA

Project description:Chouguiyu sequencing1

| PRJNA661709 | ENA

Project description:Chouguiyu metagenome

| PRJNA1503667 | ENA

Peptidome in Chouguiyu at different fermentation time

Project description:Peptidome in Chouguiyu after fermentation for 0,4,and 8d using Easy-nLC 1200 UPLC-Q Exactive HF-X tandem mass.

2022-10-15 | PXD033251 | Pride

Project description:different brands of Chouguiyu

| PRJNA715349 | ENA

Project description:different brands of Chouguiyu

| PRJNA715369 | ENA

Metaproteomic Analysis of Microbial Communities and Functional Potential in Chouguiyu

Project description:Five commercial Chouguiyu samples from different fermentation enterprises were collected and pooled for metaproteomic analysis. The microbial proteins were identified using high-resolution LC-MS/MS, and functional annotation was performed based on databases including UniProt, GO, andKEGG.

2026-08-01 | PXD082045 |

Project description:The microbiome in Chouguiyu (CGY) prepared using mandarin fish with different storage methods

| PRJNA1278950 | ENA

Nassar2022 - Microbiome sequencing NER model

Project description:Microbiome sequencing model is a Named Entity Recognition (NER) model that identifies and annotates microbiome nucleic acid sequencing method or platform in texts. This is the final model version used to annotate metagenomics publications in Europe PMC and enrich metagenomics studies in MGnify with sequencing metadata from literature. For more information, please refer to the following blogs: http://blog.europepmc.org/2020/11/europe-pmc-publications-metagenomics-annotations.html https://www.ebi.ac.uk/about/news/service-news/enriched-metadata-fields-mgnify-based-text-mining-associated-publications

2022-02-21 | MODEL2202170012 | BioModels

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data